LILRB3 and nonpapillary renal cell carcinoma: The experimental results revealed that reducing LILRB3 expression in ccRCC cells via RNA interference significantly modulates the expression of key proteins in the PI3K/AKT/mTOR signaling pathway and the immune checkpoint molecule PD-L1.